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Abstract: In this research two dibenzylideneacetone (DBA) analogs compounds: (1E,4E)-1-(4-(dimethylamino)phenyl)-5-(4-methoxyphenyl)
penta-1,4-dien-3-one (DBA-1) and (1E,4E)-1-(4-methoxyphenyl)-5-(4-nitrophenyl)penta-1,4-dien-3-one (DBA-2) were loaded in poly(lactic 
acid) (PLA) membranes. These DBA analogs can be applied in the development of controlled drug release systems.  PLA membranes were ela-
borated by solvent casting. It was found that these fluorescent compounds can cause a small percentage of hemolysis in human red blood cells 
in the concentration range of 200-500 µg/mL. Therefore, they can be considered non-toxic at these concentrations. Hydrolytic degradation of 
PLA membranes loaded with DBA analogs was studied at a temperature of 37 °C under acid, neutral, and basic pH conditions for a maximum 
time of six weeks. This hydrolysis was monitored by measuring the loss of mass of the membranes, changes in pH environments, variations in the 
molecular weight of the PLA matrix, and changes in surface morphology observed through Scanning the Electron Microscopy (SEM) technique. 
The amount of DBA analog released during the degradation time was determined by UV-visible spectrophotometry, and so, the release profile. 
Employing SEM, it was observed that the membranes presented a major degradation under basic pH conditions, with a higher percentage of 
release in an acid medium for both DBA analogs studied.
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optical effects (NLO)18 being applied in areas such as photo-
dynamic therapy (PDT),19 in two-photon excitation microscopy 
(TPEF/2PEF),20 electrical switches, 21 in 3D microfabrication 22 
and optical limitation.23
Figure 1. The general structure of Dibenzylideneacetone (DBA)
Despite the great potential and novel properties that curcu-
Introduction
One of the natural compounds that have been studied 
extensively in recent years is curcumin and its analog com-
pounds: chalcone and dibenzylideneacetone.1-6 These com-
pounds exhibit different biological properties and have gen-
erated interest in the scientific community, especially in the 
dibenzylideneacetone analogs. Dibenzylideneacetone (gener-
ally abbreviated as DBA) is a curcumin analog which chemical 
structure (see Fig. 1) consists of an α, β-unsaturated ketone 
with two aromatic rings interconnected by a bridge conjugat-
ed to a carbonyl group in the center. Several DBA analogs have 
interesting pharmacological properties such as antioxidants,7,8 
anticancer, 9-11 anti-inflammatory 12 and antiparasitic.13-16 Also, 
they have been used as an active ingredient in sunscreens8,17 
due to their high extinction coefficient in the ultraviolet region, 
and recently it has been evaluated that they exhibit non-linear 
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min analogs possess in the medicinal area, some of their de-
rivatives and analog compounds are still poor in blood-brain 
barrier (BBB) penetration and are unstable in vivo.24,25 These 
problems can be overcome with the use of liposomes, micel-
les, phospholipid complexes, membranes, and nanoparticles 
which are promising novel formulations. They provide longer 
periods of circulation, better permeability, and resistance to 
metabolic processes of derivative and analog compounds of 
curcumin.26 An effective way to overcome this critical problem 
is to use drug delivery systems that deliver drugs or bioactive 
agents at the desired time and site of action. Potential advan-
tages of enhanced drug delivery include: (1) continued main-
tenance of drug levels in a therapeutically desirable treatment; 
(2) reduction of harmful side effects due to targeted delivery to 
a particular cell or tissue type; (3) potentially decreased amount 
of drug needed; (4) decrease in the number of doses and pos-
sibly less invasive doses, which improves patient compliance 
with the prescribed drug regimen; and (5) facilitation of drug 
delivery for pharmaceuticals with short half-lives in vivo (e.g., 
peptides and proteins).27 The ideal drug delivery system should 
have the same release rate without changing in time.28 Delivery 
systems can be developed from a variety of organic and inor-
ganic compounds such as polymers, lipids (liposomes, micro-
emulsions), amphiphilic molecules, dendrimers, nanoparticles 
of zinc oxide, and titanium oxide,29-30 membranes and scaffolds 
obtained by electrospinning.31
In the field of drug delivery, biodegradable polymeric nano-
structures play an essential role due to their beneficial proper-
ties such as a high biocompatible with cells and tissues, high 
stability, that they do not cause thrombosis, do not activate 
neutrophils, and these structures are biodegradable.32,33 But 
sometimes the encapsulation process could be inefficient and 
also the quantification of the delivery way could be inexact;34 
on the other hand, loading active compounds in macroscopic 
polymeric matrices as membranes can help evaluate their re-
lease profile in a more detailed way. Today, the term “mem-
brane” covers a variety of materials and structures with very 
different properties. For example, membranes are used to pro-
duce potable water by reverse osmosis seawater desalination 
at bearable costs. Membranes are key components in medical 
devices and the separation of molecular mixtures in the chemi-
cal industry, biotechnology, pharmacology, and food process-
ing.35 Membrane science has become an interdisciplinary affair 
with contributions from physical chemistry, materials and life 
sciences, and process engineering. 
In this case, the fabrication of membranes represents a 
simple method, which presents a high loading capacity, does 
not alter the loaded active compound, and allows a more de-
tailed controlled release study because these structures are 
macroscopic and robust. Hence, their weight variations and 
viscosimetric molecular weight can be determined easily.
Taking into account the previous information, in this re-
search, these two DBA analogs DBA-1 and DBA-2 (Fig. 2), 
were loaded in membranes using a poly-lactic acid (PLA) as a 
matrix. Previous reports indicate that these compounds have 
antimalarial properties 16 and have high quantum yields,36 
which indicate that these compounds are fluorescent. This 
property represents a great advantage because it allowed the 
monitoring of the molecules in the release process. Also, future 
applications would allow their monitoring within the patient’s 
body using biosensors,37 chemosensors,38 or Single Molecule 
Detection (SMD).39 In this way, the efficacy of the treatment can 
Figure 2. The chemical structures of dibenzylideneacetone DBA 1 and DBA 2 analogs.
be evaluated, as well as its possible uses in biomedical, bio-
technological, and pharmacological applications.
Experimental
Reagents
The analog compounds of DBA 1 and DBA 2 were previously 
prepared in the Laboratory of Organic Synthesis Laboratory.36 
Poly (lactic acid) (L/D) from HIMEDIA was used as the polymer 
matrix, and chloroform from Fisher Scientific (HPLC grade) was 
used as the common solvent for both PLA and DBA analogs. 
For the study of the different pH conditions of the hydrolytic 
degradation, the following reagents were used: sodium acetate 
trihydrate from Merck Millipore (99%), acetic acid from Sigma-
Aldrich (99.8%), monosodium phosphate from J.T. Baker (98%), 
disodium phosphate from Riedel-de Haën (99.5%), ammonium 
chloride from Baker analyzed (99.7%) and ammonia from Merck 
Millipore (25%). A lactic solution from Ringer IPS from Venezuela 
for the dissolution of samples in vitro hemocompatibility tests 
and Triton X-100 from Merck used as a positive control in these 
tests.
Apparatus 
For the study of hydrolytic degradation, a Boekel Scientific 
brand thermostatic bath was used. An Adventurer OHAUS analyti-
cal balance was used to measure the mass in the membranes be-
fore and after the degradation process; an Oakton pH11 Meter 
digital pH meter model 35614-80 was used to prepare buffer 
solutions and monitor the pH changes in the degradative me-
dium of the polymeric matrices. Changes in the morphology of 
PLA membranes during hydrolytic degradation were observed 
through a JEOL JSM6390 scanning electron microscope. A Ubbe-
lohde-Schott-Geräte capillary viscometer, capillary #I (capillary 
diameter: 0.63 mm), type 501 10 / I was used to obtaining the data 
to calculate the molecular weight of neat PLA and to determine the 
drop in molecular weight of the PLA membranes loaded and un-
loaded. An Agilent 8453 UV spectrophotometer with a diode array 
was used to determine the amount of DBA released during the de-
gradation process.
Hemocompatibility test of DBA analogs
The hemolysis test was performed according to ISO 10993-4 
(15) standards40,41 in previously sterilized 1.5 mL microcentrifuge 
tubes. The positive control was a 1% v/v solution of Triton 
X-100; the negative control was a Ringer’s lactic solution with 
Alcántara Blanco et al.
 INTERNATIONAL JOURNAL OF ADVANCES IN MEDICAL BIOTECHNOLOGY - IJAMB 10 Vol. 4 N.1, 2021
1% DMSO; For DBA analogs samples, solutions of 200 and 500 
µg/mL were prepared with 1% v/v DMSO and Ringer’s solution 
in 5mL volumetric flasks.
Human blood donated with prior consent was collected 
in a sterile environment in 5 mL BD Vacutainer® tubes which 
contained lithium/sodium heparin as an anticoagulant. The 
blood sample was transferred to a 15 mL falconTM tube and 
centrifuged at 2000 rpm for 10 min. After the blood components 
had been separated, several washes were carried out with the 
Ringer solution to obtain a 100% suspension of erythrocytes. 
Subsequently, a 2.5% erythrocyte suspension was prepared, 
from which 800 µL was taken and mixed with 200 µL of each 
DBA in microcentrifuge tubes. These tubes were incubated for 
an hour at 37 ° C. After this time, each tube was centrifuged 
at 1500 rpm for 5 min, and the absorbance of the supernatant 
at 540 nm was measured. The percentage of hemolysis was 
determined employing the following equation (1):
PLA membranes loaded and unloaded with DBA 1 and 
DBA 2 analogs
5% w/v solutions of PLA in chloroform were prepared in 
25 mL volumetric flasks. Aliquots of 3 mL of this solution were 
taken and added to circular glass molds into a laboratory fume 
hood. The solvent was slowly evaporated at room temperature. 
After approximately 12 hours, the formation of transparent 
membranes was observed, and then they were carefully 
removed. Loaded PLA/DBA membranes elaboration was similar 
to PLA membranes. However, in these loaded membranes, 
PLA and DBA compounds were dissolved separately with 
chloroform. Later each one was added in the same flask until 
brought to volume 25 mL with the necessary solvent. The 
ratios used for loading were 10 and 20 µg of DBA per mg of 
PLA. Likewise, the solvent was allowed to evaporate, observing 
the formation of membranes loaded with DBA analogs. The 
fluorescent character of the membranes was also evidenced 
using ultraviolet light.
Hydrolytic degradation of PLA membranes
The hydrolytic degradation of the membranes was studied in 
function of time: two, four, and six weeks. This task was carried 
out by preparing three 0.2 M buffer solutions. An acid pH 4.85 
buffer solution (sodium acetate trihydrate/acetic acid), a neutral 
pH 7.54 buffer solution (monosodium phosphate/monosodium 
phosphate), and a basic pH 9.20 buffer solution (ammonium 
chloride/ammonia). Each membranes samples were then 
placed into separate test tubes containing the respective buffer 
solution. The weight of all membranes was registered at zero 
time (before degradation). After, the test tube was introduced 
into a thermostatic bath at a temperature of 37 ° C for six weeks.
Experimental evidence of hydrolytic degradation of 
membranes
pH changes
Once the degradation time had elapsed, the remaining 
pieces of membranes were carefully separated from the buffer 
solutions. The pH of these remaining solutions was measured 
and stored to determine the amount of DBA released during the 
degradation process.
Loss of membrane weight
Pieces of membranes separated from the buffer solutions 
after the degradation weeks were completely dried at 37 ° C in 
an oven for 24 hours. Then, they were weighed on an analytical 
balance (w ± 0.0001) g.
Viscometric molecular weight measurement
The average molecular weight (Mv) of PLA and PLA/DBA 
membranes was determined by capillary viscometry technique. 
First, diluted PLA/CHCl3 solutions were prepared from a 1% w/v 
stock solution. Second, the flow time of each polymer solution 
was measured using a digital stopwatch. With this procedure, 
the intrinsic viscosity [ɳ] is obtained, and it is possible to 
determine the viscosimetric molecular weight (Mv) applying 
the Mark-Houwink-Sakurada equation (𝜂=𝐾×𝑀𝑣𝑎). 42 The 
viscometric constants for the PLA / CHCl3 case study at 25 ° C, 
are: a = 0.777 and K = 0.0131 (Rojas, et al., 2014).
Morphological changes of PLA membranes observed 
by SEM
The surface morphology of each membrane was observed 
before and after hydrolytic degradation using Scanning Electron 
Microscopy (SEM) JEOL JSM6390; the applied voltage was set 
to 15-20 kV. A coating with a thin layer of gold was necessary 
for the SEM analysis of the samples, which was carried out with 
a metallization sputter-coater Blazers-SCD-03. 
Determination of the released quantity of DBA analogs
Once the hydrolytic degradation study was over, the 
aqueous buffer solutions stored were subjected to liquid-
liquid extraction with CHCl3. The organic phase was dried 
over anhydrous magnesium sulfate and then filtered. Next, 
this organic phase was brought to a known volume, and the 
absorbance was measured in a UV-Visible spectrophotometer 
to finally determine the amount of DBA released at the different 
degradation times.
Results and discussion
Hemocompatibility study of DBA 1 and DBA 2
The scientific literature report that PLA is a biodegradable 
polymer that does not generate adverse effects on the cells and 
tissues. 43 But when loading a compound within a polymeric 
matrix of PLA, in this case, DBA analogs, it is essential to study 
the interactions of these compounds with the membrane 
of red blood cells (RBC) since they can cause lysis of these 
cells. Besides, they can negatively affect the safety and 
biocompatibility of the structures loaded with this compound. 44 
Hemoglobin release was used to quantify the hemocompatible 
properties of DBA analogs. The way to evaluate this was 
through UV/visible spectrophotometry. Fig. 3a shows the 
qualitative hemolysis of the samples of DBA 1 and DBA 2 at 200 
and 500 µg/mL, along with the positive and negative control. 
It was qualitatively observed that these samples were very 
similar to those of the negative control, presenting little lysis 
compared to the positive control. The hemolysis percentages 
of each DBA analog at the two concentrations studied were 
obtained employing equation 1. According to ISO 10993-4 (15) 
standards, samples with a hemolysis percentage of less than 
5% are considered non-toxic. Samples with a percentage of 
hemolysis between 2-5% are classified as mildly hemolytic, 
while those with a percentage of hemolysis less than 2% are 
classified as non-hemolytic. 40 Fig. 3b) shows that both DBA 
analogs turn out to be non-hemolytic and mildly hemolytic at 
the concentrations studied.
%𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻 = 𝑆𝑆𝑆𝑆𝐻𝐻𝑆𝑆𝐻𝐻𝐻𝐻 𝑆𝑆𝑎𝑎𝐻𝐻𝐻𝐻𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝐻𝐻 −  𝑎𝑎𝐻𝐻𝑎𝑎𝑐𝑐𝑎𝑎𝐻𝐻𝐻𝐻
(+) 𝑆𝑆𝑎𝑎𝐻𝐻𝐻𝐻𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝐻𝐻
 𝑎𝑎𝐻𝐻𝑎𝑎𝑐𝑐𝑎𝑎𝐻𝐻𝐻𝐻 (−)𝑆𝑆𝑎𝑎𝐻𝐻𝐻𝐻𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝐻𝐻 −  𝑎𝑎𝐻𝐻𝑎𝑎𝑐𝑐𝑎𝑎𝐻𝐻𝐻𝐻 (+)𝑆𝑆𝑎𝑎𝐻𝐻𝐻𝐻𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝐻𝐻 𝑥𝑥 100%
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A)
 
be seen in Fig. 4, where the SEM micrographs of both mem-
branes that are not loaded and those loaded with DBA 1 and 
DBA 2, in ratios of 10 and 20 µg of DBA per mg of PLA, are 
shown. The loaded membranes have the characteristic color 
of the corresponding DBA. The membranes obtained have a 
certain flexibility and are translucent, which is conferred to the 
properties of amorphous PLA.45 Morphologically, they all have 
a rough surface, although macroscopically, they look smooth. 
This characteristic could be due to solvent evaporation. This 
morphology is similar to the PLA membranes obtained in other 
work.46
Figure 3. a) Qualitative assay of the hemocompatibility test of DBA analogs with the positive control and the negative control after 
incubation and the centrifugation process; b) graphic representation of the percentage of hemolysis obtained in human erythrocytes 
after incubation for 45 minutes at 37ºC with the DBA analogs at different concentrations.
B)
Obtaining unloaded PLA membranes and loaded PLA 
membranes with DBA analogs
The surface of membranes obtained by solvent casting can 
Figure 4. SEM micrographs of the surface of PLA membranes: 1) unloaded, 2) loaded with 10 µg of DBA 1, 3) loaded with 20 µg 
of DBA 1, 4) loaded with 10 µg of DBA 2 and 5) loaded with 20 µg of DBA 2.
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Study of hydrolytic degradation of membranes
Under hydrolytic degradation, PLA is degraded by hydroly-
sis of the ester bond in oligomers.47 This hydrolytic degradation 
of the ester groups can follow different routes: acid-catalyzed, 
base-catalyzed, and uncatalyzed.48 Furthermore, the carbox-
ylic end groups of the polymer chain act catalytically to affect 
the hydrolytic degradation of PLA in an autocatalytic and main-
tenance process.49 This hydrolytic degradation proceeds in a 
heterogeneous way: it is faster within the molecular structure 
than on the surface.50 Hydrolytic degradation is governed by 
four basic parameters: the rate constant, the amount of water 
absorbed, the diffusion coefficient of chain fragments within 
the polymer, and the solubility of degradation products.51 It has 
been reported in the literature that the hydrolytic degradation 
process can be divided into three stages: (1) initial hydration or 
water absorption of the materials; (2) gradual decrease in mo-
lecular weight without weight loss; and (3) weight loss through 
the formation and dissolution of water-soluble oligomers.52 
The results obtained from the loss of mass, pH of the medium, 
variation of the viscosimetric molecular weight, and morpho-
logical changes during the hydrolytic degradation of mem-
branes are shown below.
Loss of membrane mass
The loss of mass of the PLA membranes is an indication that 
significant amounts of soluble low molecular weight oligomers 
are removed from the polymer matrix, and they can diffuse into 
the hydrolysis medium. Fig. 5 shows the percentage of mass 
loss as a function of time in each of the unloaded and loaded 
membranes in the different degradative mediums. For bet-
ter comprehension of Fig. 5 and the following ones, unloaded 
membranes were called PLA, the loaded ones with DBA 1 in 
proportions of 10 and 20 µg of DBA per mg of PLA were called 
DBA 110 and DBA 120 respectively, and for those loaded with 
DBA 2 they were called DBA 210 and DBA 220. It is observed 
that membranes loaded with DBA analogs are the ones that 
lose the highest amount of mass in contrast to the unloaded 
ones. This observation could indicate the possible release of 
the loaded compound from the polymeric matrix. The mem-
brane loaded with DBA 220 in the basic medium presented 
the highest mass loss. Membranes subjected to a degradative 
medium of acid and neutral pH lose a small amount of mass. It 
can be inferred that in basic medium occurs the highest release 
of the loaded compound. In this sense, in basic medium, it is 
observed that there is a faster degradative process. 
However, a lower loss of mass does not mean that a deg-
radative process is not taking place. In amorphous regions, 
random hydrolytic cleavage of ester bonds generates polymer 
chains with molecular mobility,53 allowing cleavage-induced 
Figure 5. Loss of mass of the unloaded PLA membranes and loaded PLA membranes with DBA analogs as a function of degrada-
tion time at 37ºC in different buffer solutions: A) pH 4.85, B) pH 7.54 and C) pH 9.2.
crystallization to occur and thinner crystals to form. Conse-
quently, mass is conserved. On top of that, in hydrolytic deg-
radation, short, hydrophobic, and insoluble chains are also 
generated. These chains could remain within the structures, 
resulting in an observation of a slight reduction in the sample 
mass in acid and neutral pH environments.52,54 
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Variation of the Molecular Weight of PLA in the mem-
branes as a function of the hydrolysis conditions
Another way to visualize the hydrolytic degradation process 
is by measuring the changes in molecular weight. During the 
hydrolytic degradation, the diffusion of the small molecular 
weight oligomers formed by the cleavage of the polymer chain 
causes a decrease in the molecular weight of the polymer matrix. 
There is a decrease in the viscosimetric molecular weight (Mv) 
in all membranes (Fig. 6). The higher loss of molecular weight 
is evidenced in the basic medium. This loss is represented 
by triangle symbols in figure 6, reaching losses of between 
50-80% of Mv. This result agrees with the loss of mass of the 
Figure 6. Decrease in molecular weight of unloaded PLA membranes and loaded PLA membranes with DBA analogs in the differ-
ent mediums as a function of degradation time at 37 ° C.
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membranes for this same medium, and it is observed that for 
acid and neutral medium, the loss of molecular weight is less, 
barely reaching around 30% loss in Mv. 
These results show that the loss of molecular weight is 
lower in loaded membranes with DBA analogs. A possible ex-
planation for this result is to consider that the protons present 
in the acid medium can interact with the loaded compound and 
delay the hydrolysis of the polymeric matrix. Therefore, causing 
a lower mass loss and a slight drop in the Mv of the membranes, 
thus being a slower hydrolytic process.
Variation of the pH in the hydrolysis medium
The variation of the pH of the hydrolysis medium during 
the degradation process was another way of monitoring the 
hydrolytic degradation of the PLA membranes. The values 
obtained during the degradation period are presented in Fig. 
7. The pH value changes markedly towards lower values for 
the basic degradative medium, unlike the acidic and neutral 
medium, which remains relatively constant. The decreases in 
pH during the hydrolytic degradation of PLA can occur for two 
reasons. First off, the degradation tends to increase the number 
of ends of the carboxylic acid chain, which autocatalyze the 
hydrolysis of the ester group. Second, only oligomers soluble 
in the environment aqueous medium are those that diffuse from 
the polymeric matrix. Before the degradation completion, the 
soluble oligomers closest to the surface can be leached out, 
while those in the core of the matrix remain trapped. As the 
last fraction begins to degrade into lactic acid, it will lead to 
the reduction of the pH in the core.55 The effect of pH on the 
hydrolytic degradation of PLA has been studied in some works. 
56-59 Even though the basic medium used in this work is not of 
such a high pH (9.2), it is observed that there is concordance 
with these previous investigations since, in these basic 
conditions, a decrease in pH over time is observed. Hence, 
it can be inferred that the degradation of PLA is faster in this 
medium than the others studied. A linear pH drop in the basic 
medium is observed for the unloaded PLA membrane, while 
for membranes loaded with DBA analogs in the same medium 
there is also a pH decay, but it is not entirely linear.
Physical and morphological evidence of hydrolytic 
degradation of membranes
The membranes showed physical changes after six weeks 
of hydrolytic degradation (Fig. 8). Among these changes, the 
loss of flexibility is observed, and they acquire a more accen-
tuated coloration. These membranes turn out to be opaque and 
fragile after the degradation process. In the basic medium, the 
membranes were entirely fragmented. In contrast, in the other 
mediums, they presented less fragility, which indicates that the 
degradation of PLA is greater in a basic medium as evidenced 
above by Mv, weight loss, and pH.
The hydrolytic degradation leads to cleavage of the poly-
meric chains of PLA. This process generates a decrease in the 
elastic properties of the polymer. In other words, a reduction 
in its Young’s modulus (E),50 a characteristic parameter of each 
material, and it is a mechanical parameter to indicate the phy-
sical stability of these membranes. In this regard, there is a sig-
nificant decrease in the elastic properties of the membranes in 
the basic medium, thus being easy to fracture. Opacity, which 
is a consequence of degradation, has been attributed to several 
phenomena: 1) light scattering due to the presence of water or 
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the presence of degradation products formed during the hy-
drolytic process, 2) due to the formation of holes in the volume 
of the sample during degradation or 3) due to the evolution in 
crystallinity of the polymeric matrix.60,61 The hydrolytic degra-
dation of the polyester chains takes place at a higher rate in the 
amorphous areas of the matrix. It is expected that this pheno-
menon increases the relative crystallinity of the sample, which 
can result in a greater opacity of the material.62-64
On the other hand, it is primordial to observe the degraded 
membranes at a microscopic level. That way, the morpholog-
ical changes in the membranes under the different degrada-
tion mediums can be distinguished (Fig. 9). It was observed 
that membranes in the acid medium presented a slight erosion 
Figure 7. Change of pH in the degradation medium of PLA membranes unloaded and loaded as a function of degradation time at  37 ° C.
Figure 8. Physical evidence of hydrolytic degradation of unloaded PLA membranes and loaded PLA membranes with DBA analogs 
in different degradative media for six weeks.
on the surface, and in some cases, such as the unloaded PLA 
membranes, a small crack was observed. In general, they re-
tain similarity with the morphology seen in the non-degrad-
ed membranes, such as the different fibrillar patterns on the 
surface and some roughness. Despite a noticeable change 
in morphology in the acid medium was not observed, these 
membranes were sensitive to the electron beam of the electron 
microscope. This phenomenon is an indication that there was 
a degradative process in the polymeric matrix. It can be no-
ticed in the membranes subjected to neutral pH, some small 
cracks and marks on their surface. Moreover, these mem-
branes turned out to be more photosensitive than those de-
graded in an acid medium. In the basic medium, more forceful 
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proceed through two different mechanisms: (i) surface or 
heterogeneous erosion and (ii) bulk or homogeneous erosion. 
65 In the case of surface erosion, polymeric degradation is 
faster than the diffusion of water into the polymeric matrix. In 
this way, degradation occurs mainly in the outermost layers of 
the polymer, thus reducing its dimensions and releasing the 
loaded compound from the outermost layer. Consequently, 
erosion only affects the surface and not the internal parts of the 
polymeric matrix, thus being a heterogeneous process.
In contrast, homogeneous erosion occurs when the dif-
cracks are observed on the surface of the membranes, and in 
the loaded with DBA 2, erosion on the surface is noticeably 
visible compared to the other mediums studied, again indi-
cating that the hydrolytic degradation of PLA at basic pH is 
the fastest.
These SEM micrographs in the basic medium corroborate 
the fact that the membranes subjected to this medium 
considerably decrease the elastic properties of PLA to 
such an extent that they are easily fragmented. In general, 
the hydrolytic degradation of PLA polymer matrices can 
Figure 9. SEM photomicrographs of the morphology of unloaded PLA membranes and loaded PLA membranes with DBA ana-
logs degraded in acid, neutral, and basic mediums for six weeks at 37 ° C.
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fusion of water is faster than the degradation of the polymer. 
Consequently, there is rapid hydration of the system that causes 
splits in the polymeric chains, thus being a homogeneous pro-
cess,66 and the compound is being released through the pores 
and/or cracks formed in the polymer matrix. These mechanisms 
are illustrated in Fig. 10. Seeing that there are cracks on the 
surface and surface size reduction in the membranes, espe-
cially for those degraded in a basic pH, it can be pointed out 
that their hydrolytic degradation could occur due to the hetero-
geneous erosion mechanism.
Release of DBA analogs present in the membranes
After analyzing the membrane degradation mechanism, it is 
predominant to study the release of the loaded compounds. 
There are many factors that influence the kinetics of the release 
of the loaded compound: 1) diffusion of the water within the 
polymeric matrix, 2) the solubility of the compound, 3) the 
polymeric degradation, the origin of aqueous pores, 4) diffusion 
of the compound and / or degradation products (oligomers) of 
the polymer within the polymer matrix, 5) changes in pH within 
the pores of the polymer matrix due to degradation products, 
6) diffusion of the compound and / or products degradation 
through the pores, 7) diffusion of hydrogen ions or hydroxide 
ions from the release medium to the polymeric structure 
altering the internal pH of the system, 8) autocatalytic effects 
during polymeric degradation, 9) osmotic effects, 10) swelling 
of the polymer, 11) convection processes, 12) adsorption and 
desorption processes, 13) polymer type and viscosity grade, 
14) temperature, 15) buffer concentration and 16)  presence of 
additives.66-72 
The degradation of PLA is critical for drug delivery 
behavior in controlled release systems based on this polymer. 
Homogeneous erosion and heterogeneous erosion combined 
with the autocatalytic effect of carboxyl groups probably disturbs 
a uniform release rate, specifically, the zero-order release 
state, which is desired when designing previous systems.73 
Furthermore, the diffusion of the drug through the polymeric 
matrix is  a mechanism that contributes to the complexity of 
the phenomenon. This last mechanism is influenced by the 
swelling characteristics of the polymeric matrix. Matrix-drug 
interactions are another critical parameter influencing drug 
delivery systems. Chemical interactions between entrapped 
compounds and the biodegradable polymer can have a strong 
effect on polymer degradation and drug release.74
The release of DBA analogs in PLA membranes is shown 
through the release profiles in the different media and amounts 
studied (see figure 11). It can be seen that the highest release of 
both DBA analogs occurs in an acid medium in the proportions 
of 10 µg of DBA per mg of PLA and that after two weeks, a 
maximum amount of compound is released, which then decays 
over time. In the fourth week, an increase in the release of DBA 
120 and DBA 210 is observed in the basic medium. In addition, 
an increase in the release of DBA 210 in the neutral medium 
and a decrease of DBA 110, DBA 120, and DBA 220 release in 
the neutral medium.
Membranes with a higher amount of load presented a lower 
release of the DBA than those containing a lower amount of DBA. 
According to the analysis and observation of SEM micrographs, 
it can be inferred that membrane degradation is favored by 
heterogeneous erosion. Within these systems, drug release 
is due to the degradation/erosion of the polymer surface, 75 
thus generating a slower release of the loaded compound in 
the membranes. Another factor that may be involved in this 
observation is the possible interactions between the DBA and 
PLA. These interactions can cause a slow release of DBA. 
DBA analogs are hydrophobic compounds (two conjugated 
aromatic rings and alkenes) that could restrict the water 
absorption in the polymeric matrix, thus reducing the 
degradation rate and favoring the heterogeneous erosion 
mechanism. It is important to mention that membranes were 
not completely degraded. This leads to infer that, at longer 
study times, a higher degradation of the polymeric matrices 
and a higher DBA analogs release could be observed. Another 
interesting observation is that in the acid medium the release of 
Figure 10. Schematic illustration of the principles of heterogeneous or surface erosion of polymer membranes; and homoge-
neous or bulk erosion into the polymer matrix. From an initial time (to) to a final time (t2) during hydrolysis.
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both DBA analogs is higher than the other mediums. Although 
the degradation in the acid medium occurs slowly compared to 
the neutral and basic medium. This pattern has been evidenced 
by the moderate loss of both weight and viscosimetric molecular 
weight of the membranes, the pH variations of the degrading 
medium, and the few morphological changes observed by SEM 
on their surfaces in the acid medium. This could indicate that 
protons present in acid pH interact with the DBA. Therefore, 
there is a decrease in the degradative process and an increase 
in the release of the loaded compound.
In Figure 11, the characteristic controlled release profiles 
Figure 11. Comparison of release profiles of conventional formulations, ideal release systems, and sustained-release with the 
release profiles obtained from DBA analogs in polymeric in PLA/DBA membranes.28
in conventional formulations, in ideal release systems, and 
sustained release, are compared with the release profiles 
obtained for the membranes in the different degradation 
mediums studied. It is observed that the profile more similar 
to the ideal controlled release system profile is the DBA 210 
membrane in the neutral medium, being an interesting result 
since pH (7.54) is quite close to the pH of the human blood. 
The release profiles of DBA 110 and DBA 210 show a similarity 
to the conventional formulations profiles in the time studied. 
The basic medium profiles for the DBA 110 and DBA 210 tend 
to be sustained release profiles. For membranes with a higher 
load of DBA 1, the release profile in acid and neutral mediums 
is similar to the sustained-release profile. On the other hand, 
for membranes with a higher load of DBA 2, their release during 
the study time was so low that not characteristic behavior 
regarding its release is observed.
Conclusions
Qualitative and quantitative hemocompatibility tests 
demonstrated that free DBA analogs do not present hemoly-
sis at concentrations between 200-500 µg/mL. Therefore, they 
can be considered non-toxic at these concentrations. Hence, 
the PLA/DBA membranes can be considered non-toxic. In this 
way, it is safe to load this compound in PLA-based polymeric 
matrices in this concentration range and use it as a controlled 
release system. The studies of the hydrolytic degradation of 
the membranes under the different conditions confirmed the 
type of degradation process reported in the literature. Also, 
they confirmed that the pH of the medium is an important pa-
rameter that influences the rate of degradation. Although the 
basic medium induces a greater physical disintegration of the 
membranes, it was obtained that the highest percentage of re-
lease was observed in an acid medium for both DBA analogs. 
According to all results, the structures studied may have appli-
cations in the development of controlled drug release systems 
or load/ release of other biomolecules used in some biotech-
nological applications.
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